FirmaIQ
Org.nr 998 036 011 2022 → 2023 Year-over-year analysis

4 HEALTH INNOVATION NORGE AS: årsregnskap 2023 vs 2022

Shrank 99% on revenue, weaker earnings, cash halved-plus

approved 2024-06-28; registry 2024-07-20; journal 2024 658506

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2023 with 2022 for 4 HEALTH INNOVATION NORGE AS. Revenue 160.0k NOK → 1 160 NOK (-99.3%). Net result +2.85m NOK → +568.3k NOK. Equity 562.5k NOK → 1.13m NOK.

On the constructive side: equity strengthened; current ratio back above 1×. Pressures included: revenue fell; operating result weakened; net result weakened.

Net tougher year on the published lines.

At a glance

Scorecard

Revenue
160.0k NOK 1 160 NOK
-99.3%
Operating result
+1.01m NOK -38.3k NOK
-103.8%
Net result
+2.85m NOK +568.3k NOK
-80.0%
Equity
562.5k NOK 1.13m NOK
+101.0%
Cash
24.3k NOK 2 533 NOK
-89.6%
Total assets
2.85m NOK 3.44m NOK
+20.8%

What improved

  • ↑

    Equity strengthened

    Book equity 562.5k NOK → 1.13m NOK (equity ratio 19.7% → 32.8%). Calculated

  • ↑

    Current ratio back above 1×

    Current ratio 0.15× → 75.91×. Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 160.0k NOK to 1 160 NOK (-99.3% YoY). Calculated

  • ↓

    Operating result weakened

    Operating result +1.01m NOK → -38.3k NOK (op. margin 631.4% → -3301.9%). Calculated

  • ↓

    Net result weakened

    Net result +2.85m NOK → +568.3k NOK (net margin 1779.0% → 48994.1%). Calculated

  • ↓

    Cash fell

    Bank deposits 24.3k NOK → 2 533 NOK (-89.6% YoY). Calculated